Background and Purpose: Quinpirole (a dopamineD2‐like receptor agonist) inhibits the cardioaccelerator sympathetic outflow in pithed rats by sympathoinhibitoryD2‐like receptors. The present study was designed to identify pharmacologically the specificD2‐like receptor subtypes (i.e.D2,D3andD4) involved in this sympathoinhibition by quinpirole.Experimental Approach: One hundred fourteen maleWistar rats were pithed, artificially ventilated with room air and prepared for either preganglionic spinal (C7‐T1) stimulation of the cardioaccelerator sympathetic outflow (n= 102) or i.v. bolus injections of exogenous noradrenaline (n= 12). This approach resulted in frequency‐dependent and dose‐dependent tachycardic responses, respectively, as previously reported by our group.Key Results: I.v. continuous infusions of quinpirole (0.1–10 μg kg−1 min−1), but not of saline (0.02 mL min−1), dose‐dependently inhibited the sympathetically induced tachycardic responses. Moreover, the cardiac sympathoinhibition induced by 3 μg kg−1 min−1quinpirole (which failed to affect the tachycardic responses to i.v. noradrenaline) was: (i) unchanged after i.v. injections of the antagonistsSB‐277011‐A(D3; 100–300 μg kg−1) or L‐745,870 (D4; 30–100 μg kg−1); and (ii) markedly blocked and abolished by, respectively, 100 and 300 μg kg−1of theD2preferring receptor subtype antagonist L‐741,626. These doses of antagonists, which did not affectper sethe sympathetically induced tachycardic responses, were high enough to completely block their respective receptors.Conclusions and Implications: The cardiac sympathoinhibition induced by 3 μg kg−1 min−1quinpirole involves the dopamineD2receptor subtype, with no evidence for the involvement of theD3orD4subtypes. This provides new evidence for understanding the modulation of the cardioaccelerator sympathetic outflow.